Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BD Combinations of oral blood glucose lowering drugs
A10BD19 Linagliptin and empagliflozin
D10588 Empagliflozin and linagliptin <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Combinations
Empagliflozin/ Linagliptin
D10588 Empagliflozin and linagliptin
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D10588 Empagliflozin and linagliptin
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03035 Combination of DPP-4 inhibitor and SGLT2 inhibitor
D10588 Empagliflozin and linagliptin
Transporter substrate
DG01665 ABCB1 substrate
D10588 Empagliflozin and linagliptin
DG01913 ABCG2 substrate
D10588 Empagliflozin and linagliptin
Drug classes [BR:br08332]
Antidiabetic agent
DG02044 Hypoglycemic agent
D10588 Empagliflozin and linagliptin
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10588
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D10588